Ophthalmology in Tonawanda, NY
3 verified ophthalmology doctors in Tonawanda.
Ophthalmologists are physicians who provide complete eye care, including surgery for eye disease.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the New York State Board for Professional Medical Conduct
Dr. Sara Sirkin, MD
Ophthalmology
CMS Open Payments· $721.15 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$721.15
Total received
14
Transactions
4
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total ranks around the 81th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Sara Sirkin do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Nicholas Stathopoulos, MD
Ophthalmology
CMS Open Payments· $1,274 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,274
Total received
56
Transactions
7
Paying companies
Top paying companies
Among the 23,451 ophthalmology doctors we've analyzed, about 60% received any industry payment (median $348 among those who did). This doctor's total ranks around the 88th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US ophthalmology doctors.
Payments to Nicholas Stathopoulos do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Russell Knapp, MD
Ophthalmology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.